MOA Biotech ApS: Financial statements 2023
CVR: 38844679
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MOA Biotech ApS (CVR 38844679) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -9,250 and a net result of DKK -3,370 compared with DKK -17,120 the year before. Equity in the 2023 report amounted to DKK 19,317. The solvency ratio was 79.4%.
- Gross Profit
- DKK -9,250
- Profit/Loss
- DKK -3,370
- Equity
- DKK 19,317
- Total Assets
- DKK 24,316
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -9 t. | -3 t. | 19 t. | - |
| 2022 | - | -7 t. | -17 t. | 23 t. | - |
| 2021 | - | -8 t. | -8 t. | 40 t. | - |
| 2020 | - | -8 t. | -8 t. | 48 t. | 0 |
| 2019 | 40 t. | 30 t. | 30 t. | 56 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
MOA Biotech ApS has published its annual report for 2022. Gross profit came to DKK -6,500, and the net result was DKK -17,120.
About MOA Biotech ApS
MOA Biotech ApS is a Danish company of the type Anpartsselskab based in Odense S, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Morten Østergaard Andersen. The company is owned by Morten Østergaard Andersen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -9,297 and a net result of DKK -9,297 compared with DKK -8,899 the year before. Equity in the 2025 report amounted to DKK 1,121.